Is Core Scientific (CORZ) Fairly Valued On Its AI Pivot And Q3 Earnings?

Core Scientific (CORZ) is overhauling its business to focus on data center colocation for artificial intelligence clients and is stepping away from Bitcoin mining, just as it reports strong third quarter revenue and a sharp swing to profit.

The share price reaction has been mixed, with Core Scientific closing at US$12.72 after a 1 day share price return of 8.16%. The 30 day share price return is down 17.46% and the 1 year total shareholder return has declined 34.06%, suggesting recent enthusiasm around the AI colocation shift and earnings has not yet erased a longer period of weaker momentum.

Scan other AI infrastructure plays riding similar catalysts by reviewing our hand picked 53 AI infrastructure stocks alongside Core Scientific’s pivot away from Bitcoin mining.

Core Scientific now trades on a new AI colocation narrative while still carrying scars from a weak 1-year return. Do you lean into the pivot today, or wait for a cleaner entry based on upcoming numbers?

Most Popular Narrative: 30% Undervalued

On the Simply Wall St Community view, Core Scientific’s fair value of $12.76 sits almost level with the last close at $12.72. This keeps attention firmly on how its AI colocation shift interacts with Texas power approvals rather than on a big pricing gap.

Core Scientific reported Q3 revenue of $232.9 million against an aggregated consensus of $193.2 million, and adjusted EBITDA of $133.6 million, a 57% margin, up from 25%. Net income of $1.2 billion came from a non-cash gain on warrants, so I would ignore it. The market's concern lies elsewhere, because the beat came from capacity already billing, while the next leg of growth sits in Texas.

See why 1 investors see Core Scientific as 0% undervalued.

Result: Fair Value of $12.76 (ABOUT RIGHT)

Still, Core Scientific’s pivot depends on Texas power approvals and large AI clients following through on contracts, so any delay or policy shift could drag on sentiment.

Find out about the key risks to this Core Scientific narrative.

Another View: Core Scientific Looks Expensive On Sales

Fair value at $12.76 paints Core Scientific as roughly in line with its recent $12.72 close. A different lens using the P/S ratio tells a tougher story. The stock trades at 6.9x sales, compared with 3.5x for the wider US Software group and 3.3x for peers.

That gap suggests you are paying a premium for Core Scientific’s AI colocation story, even before profitability arrives. The fair ratio of 6.1x hints at a level the market could move toward if enthusiasm cools or execution slips. Is that extra multiple a risk you are comfortable carrying at this stage?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed signals on Core Scientific can either spark hesitation or curiosity. Consider both perspectives as the story continues to develop, then review the 1 key reward and 3 important warning signs.

Looking for more Core Scientific sized investment ideas?

You have seen how Core Scientific stacks up. Now widen your field of vision and pressure test your portfolio ideas against other opportunities before the market wakes up.

• Spot potential outperformers early by scanning our 19 high quality undiscovered gems and compare their stories with what you see in Core Scientific today.
• Strengthen your portfolio’s foundation by checking companies with the list of solid balance sheet and fundamentals (25 results) that might complement a higher risk AI infrastructure position.
• Reduce portfolio stress by reviewing 30 resilient stocks with low risk scores that can offset the volatility you accept with more speculative AI themed holdings.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com